Marine Fungal Metabolites as Potential Antidiabetic Agents: A Comprehensive Review of Their Structures and Enzyme Inhibitory Activities
Marine Drugs · 2025
DOI: 10.3390/md23040142 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, 2025. Verfasst von Zimin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric intensive Care Medicine, Hainan Women and Children's Medical Center, Haikou 570100, China. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Fungi, Diabetes Mellitus, Type 2, Aquatic Organisms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2024 Guangxi Master Graduate Innovation Program, Joint Program on Health Science & Technology Innovation of Hainan Province, the Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetes mellitus has emerged as a global public health crisis, with Type 2 diabetes (T2D) constituting over 90% of cases. Current treatments are palliative, primarily focusing on blood glucose modulation. This review systematically evaluates 181 bioactive compounds isolated from 66 marine fungal strains for their inhibitory activities against key diabetes-related enzymes, including α-glucosidase, protein tyrosine phosphatase 1B (PTP1B), dipeptidyl peptidase-4 (DPP-4), glycogen synthase kinase-3β (GSK-3β), and fatty acid-binding protein 4 (FABP4). These compounds, categorized into polyketides, alkaloids, terpenoids, and lignans, exhibit multitarget engagement and nanomolar-to-micromolar potency. The review highlights the potential of marine fungal metabolites as novel antidiabetic agents, emphasizing their structural novelty and diverse mechanisms of action. Future research should focus on overcoming challenges related to yield and extraction, leveraging advanced technologies such as genetic engineering and synthetic biology to enhance drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric intensive Care Medicine, Hainan Women and Children's Medical Center, Haikou 570100, China.
- Key Laboratory of Chemistry and Engineering of Forest Products, State Ethnic Affairs Commission, Guangxi Key Laboratory of Polysaccharide Materials and Modification, School of of Marine Science and Biotechnology, Guangx…
- College of Food and Pharmaceutical Engineering, Guangxi Vocational University of Agriculture, Nanning 530006, China.
Förderung
- 2024 Guangxi Master Graduate Innovation Program
- Joint Program on Health Science & Technology Innovation of Hainan Province
- the Natural Science Foundation of China
- Joint Program on Health Science & Technology Innovation of Hainan Province
- Hainan Province Clinical Medical Center
- the Talent Scientific Research Initiation Project of Guangxi Minzu University
- Xiangsi Lake Youth Innovation Team Project of Guangxi Minzu University
Zitieren
APA
Wang, Z., Zhao, M., Yu, Y., Kong, F., Lin, N., & Wang, Q. (2025). Marine Fungal Metabolites as Potential Antidiabetic Agents: A Comprehensive Review of Their Structures and Enzyme Inhibitory Activities. Marine Drugs. https://doi.org/10.3390/md23040142
Vancouver
Wang Z, Zhao M, Yu Y, Kong F, Lin N, Wang Q. Marine Fungal Metabolites as Potential Antidiabetic Agents: A Comprehensive Review of Their Structures and Enzyme Inhibitory Activities. Marine Drugs. 2025. doi:10.3390/md23040142
BibTeX
@article{Wang2025,
author = {Wang, Zimin and Zhao, Meirong and Yu, Yunxia and Kong, Fandong and Lin, Nanxin and Wang, Qi},
title = {Marine Fungal Metabolites as Potential Antidiabetic Agents: A Comprehensive Review of Their Structures and Enzyme Inhibitory Activities},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23040142}
}
EUVIMED